Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Platycodin D2 Targets Vimentin to Suppress Fibroblast-Myofibroblast Transition: A Novel Therapeutic Strategy Against Pulmonary Fibrosis
X. Lang, Z. Ma, C. Yao +4
bioRxiv3 Nov 2026PreprintCC BYFull textCell biologybioRxiv
Integrative network toxicology and machine learning reveal the potential role of 5-hydroxymethylfurfural in exacerbating pulmonary fibrosis
Qinghuan Yang, Fuli Li, Jiani Li +1
PLOS One2 Nov 2026Peer-reviewedCC BYFull textMolecular biology & gene regulation Developmental biologyPLOSEurope PMCPMC
The glucocorticoid receptor–autophagy axis in inflammation, immunoregulation, and cancer: a bidirectional regulatory network with therapeutic potential
Xiuping Wang, Lingxiang Mao, Yujie Li +1
Frontiers in Immunology29 Oct 2026Peer-reviewedCC BY 4.0ImmunologyCrossref
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids
Daphne J. G. Leunissen, Laura Moonen, Jan H. von Der Thüsen +16
Journal of Thoracic Oncology28 Oct 2026Peer-reviewedCC BYFull text29 citedGeneral biology OncologyHAL
Serum concentration of Surfactant protein D at diagnosis is associated with malnutrition in patients with idiopathic pulmonary fibrosis
Laurent Vernhet, Cédric Ménard, Chloe Rousseau +1
Respiratory Medicine and Research1 Sep 2026Peer-reviewedCC BY-NC 4.0Full textGeneral biologyHAL

Cite

BibTeX

@misc{barnthaler2026sobetirome,
  title = {{Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis}},
  author = {T. Barnthaler and s. Ding and T. S. Adams and K.-A. Rose and R. Rangel and J. Khoury and M. Salimi and S. Anderson and L. Lin and K. Velasco Alzate and F. Poli De Frias and G. Deluliis and F. Nicola and C. Cosme and A. Justet and X. Liu and I. Rosas and N. Kaminski and F. Ahangari},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.31.747360},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.31.747360v1},
}

RIS

TY  - UNPB
TI  - Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis
AU  - T. Barnthaler
AU  - s. Ding
AU  - T. S. Adams
AU  - K.-A. Rose
AU  - R. Rangel
AU  - J. Khoury
AU  - M. Salimi
AU  - S. Anderson
AU  - L. Lin
AU  - K. Velasco Alzate
AU  - F. Poli De Frias
AU  - G. Deluliis
AU  - F. Nicola
AU  - C. Cosme
AU  - A. Justet
AU  - X. Liu
AU  - I. Rosas
AU  - N. Kaminski
AU  - F. Ahangari
PY  - 2026
DA  - 2026/08/31
PB  - bioRxiv
DO  - 10.64898/2026.08.31.747360
UR  - https://www.biorxiv.org/content/10.64898/2026.08.31.747360v1
ER  -

Related

Cite